Treatment of subclinical mastitis in Damascus goats during lactation

This study was carried out to determine the efficacy of three treatment protocols for subclinical mastitis during lactation in Damascus goats. For this purpose intramammarian ampicillin dicloxacillin, intramuscular amoxycillin clavulonic acid and the combination of intramammarian ampicillin dicloxacillin and intramuscular amoxycillin clavulonic acid were used in goats with subclinical mastitis during lactation. The microbiological treatment rates in the intramammarian ampicillin dicloxacillin, intramuscular amoxycillin clavulonic acid and the combination of intramammarian ampicillin dicloxacillin and intramuscular amoxycillin clavulonic acid groups in the 7th and 21st days after the treatment were 62.5% and 92.5%, 62.5% and 70%, 87.5% and 87.5%, respectively. The intramammarian and intramuscular combination group was found to have a statistically higher treatment rate than other two groups on the 7th day. On the 21st day intramammarian and combination groups were found to have statistically better treatment rates than that of intramuscular group. It was concluded that the goat subclinical mastitis could be successfully treated during lactation. While the intramammarian ampicillin dicloxacillin treatment had the best treatment rates, the combination of intramuscular amoxycillin clavulonic acid was also successful. Intramuscular amoxycillin clavulonic acid as the sole treatment was not as effective as intramammarian therapy.